English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Acute Myocardial Infarction (AMI) is both a common and deadly type of cardiac event in the United States. Although the age-adjusted hospitalization rate for AMI and its in-hospital case fatality rates have both declined since the mid-1990s, there were still 634,000 inpatient admissions in 2009 for which AMI was listed as the primary diagnosis [1, 2]. Moreover, Americans suffered an estimated 610,000 first-time AMIs and 325,000 recurrent attacks, and 133,958 deaths in 2008 [2]. Because the declines in hospitalization and in-hospital mortality rates have been associated with more aggressive therapeutic interventions [1], it is impor‐ tant to evaluate the cost-effectiveness of these interventions.

Costs of Hospitalizations with a Primary Diagnosis of Acute Myocardial Infarction Among Patients Aged 18-64 Years in the United States